These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25008344)

  • 81. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
    Chan WK; Nguyen LT; Miller VP; Harris RZ
    Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10.
    Ramírez J; Mirkov S; House LK; Ratain MJ
    Drug Metab Dispos; 2015 Jul; 43(7):928-35. PubMed ID: 25870101
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Interaction between oblongifolin C and UDP-glucuronosyltransferase isoforms in human liver and intestine microsomes.
    Gao C; Shi R; Wang T; Tan H; Xu H; Ma Y
    Xenobiotica; 2015; 45(7):578-85. PubMed ID: 25714435
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
    Sun H; Zhou X; Wu B
    Xenobiotica; 2015; 45(11):945-53. PubMed ID: 26068529
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
    Paine MF; Criss AB; Watkins PB
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
    Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
    Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In vitro inhibition of human UGT isoforms by ritonavir and cobicistat.
    Algeelani S; Alam N; Hossain MA; Mikus G; Greenblatt DJ
    Xenobiotica; 2018 Aug; 48(8):764-769. PubMed ID: 28891378
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
    Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
    Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.
    Mohamed ME; Frye RF
    Drug Metab Dispos; 2011 Sep; 39(9):1522-8. PubMed ID: 21632963
    [TBL] [Abstract][Full Text] [Related]  

  • 91. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs).
    Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ
    Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Isoliquiritigenin showed strong inhibitory effects towards multiple UDP-glucuronosyltransferase (UGT) isoform-catalyzed 4-methylumbelliferone (4-MU) glucuronidation.
    Lu H; Fang ZZ; Cao YF; Hu CM; Hong M; Sun XY; Li H; Liu Y; Fu X; Sun H
    Fitoterapia; 2013 Jan; 84():208-12. PubMed ID: 23237733
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions.
    Paine MF; Oberlies NH
    Expert Opin Drug Metab Toxicol; 2007 Feb; 3(1):67-80. PubMed ID: 17269895
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies.
    Donato MT; Montero S; Castell JV; Gómez-Lechón MJ; Lahoz A
    Anal Bioanal Chem; 2010 Mar; 396(6):2251-63. PubMed ID: 20145913
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.
    Takekuma Y; Yagisawa K; Sugawara M
    Biol Pharm Bull; 2012; 35(2):151-63. PubMed ID: 22293344
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Evaluation of human primary intestinal monolayers for drug metabolizing capabilities.
    Speer JE; Wang Y; Fallon JK; Smith PC; Allbritton NL
    J Biol Eng; 2019; 13():82. PubMed ID: 31709009
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Immune-epithelial barrier interactions mediate intestinal adaptation to diverse diets.
    Avino G; Riggioni C; Comberiati P
    Allergy; 2022 May; 77(5):1636-1637. PubMed ID: 34773279
    [No Abstract]   [Full Text] [Related]  

  • 99. Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction.
    Gufford BT; Chen G; Vergara AG; Lazarus P; Oberlies NH; Paine MF
    Drug Metab Dispos; 2015 Sep; 43(9):1353-9. PubMed ID: 26070840
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
    Ainslie GR; Wolf KK; Li Y; Connolly EA; Scarlett YV; Hull JH; Paine MF
    J Pharmacol Exp Ther; 2014 Dec; 351(3):576-84. PubMed ID: 25253884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.